Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Immunology

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molimm.2013.11.015PMID 24434636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.

  2013cited by this paper
• Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.

  2012cited by this paper
• Interleukin-23: A key cytokine in inflammatory diseases

  2011cited by this paper
• The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.

  2011cited by this paper
• Possible roles of IL-27 in the pathogenesis of psoriasis.

  2010cited by this paper
• Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells.

  2010cited by this paper
• The Origin and Maturity of Dendritic Cells Determine the Pattern of Sphingosine 1-Phosphate Receptors Expressed and Required for Efficient Migration

  2010cited by this paper
• Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27

  2010cited by this paper
• Dendritic cell differentiation with prostaglandin E2 results in selective attenuation of the extracellular signal‐related kinase pathway and decreased interleukin‐23 production

  2010cited by this paper
• Role of mitogen-activated protein kinase and PI3K pathways in the regulation of IL-12-family cytokines in dendritic cells and the generation of T H-responses.

  2010cited by this paper
• The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: How a bioactive lipid mediator grew up from an “immature” vascular maturation factor to a “mature” mediator of lymphocyte behavior and function

  2009cited by this paper
• Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.

  2009cited by this paper
• Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration.

  2009cited by this paper
• Mechanisms of Disease: Psoriasis.

  2009cited by this paper
• Inhibition of ERK MAPK Suppresses IL-23- and IL-1-Driven IL-17 Production and Attenuates Autoimmune Disease1

  2009cited by this paper
• Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype.

  2008cited by this paper
• Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways.

  2008cited by this paper
• Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

  2008cited by this paper
• A rush to judgment on Th17

  2008cited by this paper
• Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages

  2008cited by this paper
• Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes.

  2007cited by this paper
• Finding a way out: lymphocyte egress from lymphoid organs

  2007cited by this paper
• Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.

  2007cited by this paper
• Sphingosine 1‐Phosphate Interferes on the Differentiation of Human Monocytes into Competent Dendritic Cells

  2007cited by this paper
• A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells

  2007cited by this paper
• Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

  2007cited by this paper
• Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system

  2006cited by this paper
• In Vitro and In Situ Expression of IL-23 by Keratinocytes in Healthy Skin and Psoriasis Lesions: Enhanced Expression in Psoriatic Skin

  2006cited by this paper
• Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

  2006cited by this paper
• Getting under the skin: the immunogenetics of psoriasis

  2005cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper
• The immunomodulator FTY720 interferes with effector functions of human monocyte‐derived dendritic cells

  2005cited by this paper
• Sphingosine 1-Phosphate ( S 1 P ) Receptor Subtypes S 1 P 1 and S 1 P 3 , Respectively , Regulate Lymphocyte Recirculation and Heart Rate *

  2004cited by this paper
• Lysophospholipid G Protein-coupled Receptors*

  2004cited by this paper
• Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

  2004cited by this paper
• Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*

  2004influential reference
• Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells.

  2004cited by this paper
• STAT 1 During Initial Th 1 Commitment for Induction of T-Bet Through Activation of Cutting Edge : Role of IL-27 / WSX-1 Signaling

  2003cited by this paper
• The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

  2003cited by this paper
• Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment1

  2003cited by this paper
• Sphingosine-1-phosphate: an enigmatic signalling lipid

  2003cited by this paper
• Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17*

  2003cited by this paper
• Sphingosine 1‐phosphate induces Chemotaxis of immature dendritic cells and modulates cytokine‐release in mature human dendritic cells for emergence of Th2 immune responses

  2002cited by this paper
• Suppression of IL-12 Production by Soluble CD40 Ligand: Evidence for Involvement of the p44/42 Mitogen-Activated Protein Kinase Pathway1

  2002cited by this paper
• Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

  2000cited by this paper
• An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

  1999cited by this paper
• Role of sphingosine kinase in Ca2+ signalling by epidermal growth factor receptor

  1999cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

  1996cited by this paper
• Interleukin-12: a proinflammatory cytokine with immunoregulatory functions.

  1995cited by this paper
• A rush to judgment on Th 17

  year unknowncited by this paper

• Innate Immune Response and Epigenetic Regulation: A Closely Intertwined Tale in Inflammation

  2024cites this paper
• New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis

  2024cites this paper
• Sphingosine-1-phosphate mediates FSH-induced cell viability but not steroidogenesis in bovine granulosa cells.

  2023cites this paper
• Psoriasis: a focus on upcoming oral formulations.

  2023cites this paper
• Signaling pathways and targeted therapies for psoriasis

  2023cites this paper
• Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases

  2023cites this paper
• Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy

  2023cites this paper
• Pathogenic sphingosine 1-phosphate pathway in psoriasis: a critical review of its pathogenic significance and potential as a therapeutic target

  2023cites this paper
• S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo.

  2022cites this paper
• Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection

  2022cites this paper
• Novel treatments for pediatric atopic dermatitis

  2021cites this paper
• Identification of Novel Biomarkers for Evaluating Disease Severity in House-Dust-Mite-Induced Allergic Rhinitis by Serum Metabolomics

  2021cites this paper
• Dendritic Cells of Mesenteric and Regional Lymph Nodes Contribute to Yersinia enterocolitica O:3–Induced Reactive Arthritis in TNFRp55−/− Mice

  2020cites this paper
• Serum Metabolomic Signatures Associated with Disease Severity in Allergic Rhinitis

  2020cites this paper
• Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!

  2020cites this paper
• Human keratinocytes use sphingosine 1-phosphate and its receptors to communicate S. aureus invasion and activate host defense.

  2020cites this paper
• Human Keratinocytes Use Sphingosine 1-Phosphate and its Receptors to Communicate Staphylococcus aureus Invasion and Activate Host Defense.

  2019cites this paper
• Microbiome and Gut Immunity: T Cells

  2018cites this paper
• Sphingolipids in early viral replication and innate immune activation

  2018cites this paper
• IL-12 and IL-23 Production in Toxoplasma gondii- or LPS-Treated Jurkat T Cells via PI3K and MAPK Signaling Pathways

  2017cites this paper
• Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

  2017cites this paper
• Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies

  2017cites this paper
• Nuclear Translocation of SGPP-1 and Decrease of SGPL-1 Activity Contribute to Sphingolipid Rheostat Regulation of Inflammatory Dendritic Cells

  2017cites this paper
• CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.

  2017cites this paper
• The Role of Dendritic Cells in Central Nervous System Autoimmunity: Focusing on Multiple Sclerosis and Emerging Therapeutics Targeting Dendritic Cells

  2016cites this paper
• IL-27: Structure, Regulation, and Variability

  2016cites this paper
• Adoptive transfer of FTY720-treated immature bone marrow-derived dendritic cells (BMDCs) significantly reduced the spontaneous resorption rate in the CBA/J × DBA/2 mouse model

  2016cites this paper
• Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.

  2016cites this paper
• Sphingolipids in spinal cord injury.

  2016cites this paper
• Regulation of Interleukin-12 Production in Antigen-Presenting Cells.

  2016cites this paper
• Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo.

  2016cites this paper
• Role of Sphingolipids in Hematological Malignancies: Lymphoproliferative Disorders

  2015cites this paper
• Sphingosine-1-Phosphate Modulates Dendritic Cell Function: Focus on Non-Migratory Effects in Vitro and in Vivo

  2014cites this paper
• HDL in innate and adaptive immunity.

  2014cites this paper